Kyverna Therapeutics, Inc 10-K for FY2025
Kyverna Therapeutics, Inc. (KYTX)
10-K
2026-03-26
For: 2025-12-31
View Original
Added on
April 09, 2026
About this 10-K
Kyverna Therapeutics, Inc filed this 10-K on March 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $161.31M
- compared with a net loss of $127.48M a year earlier
- Diluted EPS
- -$3.64
- compared with -$3.33 a year earlier